Artwork

Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Haemato-oncology experts discuss current considerations and future strategies for CAR T-cell therapies in patients with R/R MCL

42:55
 
Share
 

Manage episode 394495451 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

touchIN CONVERSATION for touchONCOLOGY

Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma.

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchoncology.com

  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 394495451 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

touchIN CONVERSATION for touchONCOLOGY

Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma.

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchoncology.com

  continue reading

102 episodes

Todos los episodios

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide